Conexeu Sciences Inc. - Common Stock (NQ:CNXU)

4.520 -0.480 (-9.60%)

Streaming Delayed Price Updated: 11:16 AM EDT, Sep 15, 2026 Add to My Watchlist

Price and Volume

Volume	54,599
Open	5.000
Bid (Size)	4.500 (1,000)
Ask (Size)	4.520 (300)
Prev. Close	5.000
Today's Range	4.400 - 5.000
52wk Range	4.190 - 18.79
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.

August 18, 2026

From Equity Insider

Via GlobeNewswire

The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.

August 18, 2026

Issued on behalf of Conexeu Sciences Inc.

From American News Group

Via GlobeNewswire

Performance

YTD	-65.4%	-65.4%
1 Month	-53.8%	-53.8%
3 Month	-54.0%	-54.0%
6 Month	-65.4%	-65.4%
1 Year	-65.4%	-65.4%

More News

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

August 12, 2026

From USA News Group

Via GlobeNewswire

Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It

August 11, 2026

From Biotech Insider

Via GlobeNewswire

Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

August 04, 2026

From American News Group

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 15, 2026

Via Benzinga

A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next

July 15, 2026

From Energy Metal News

Via GlobeNewswire

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Via GlobeNewswire

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

June 25, 2026

From Biotech Insider

Via GlobeNewswire

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

June 18, 2026

From Biotech Insider

Via GlobeNewswire

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

June 16, 2026

From World Street Intelligence

Via GlobeNewswire

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

June 09, 2026

From Equity Insider

Via GlobeNewswire

Before the IPO: 4 Companies That Rewarded Investors Who Got In Early ↗

June 04, 2026

Via MarketBeat

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

May 27, 2026

From Biotech Insider

Via GlobeNewswire

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

May 22, 2026

From Energy Metal News

Via GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

From World Street Intelligence

Via GlobeNewswire

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

May 21, 2026

Via Newsfile

Frequently Asked Questions

Is Conexeu Sciences Inc. - Common Stock publicly traded?

Yes, Conexeu Sciences Inc. - Common Stock is publicly traded.

What exchange does Conexeu Sciences Inc. - Common Stock trade on?

Conexeu Sciences Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Conexeu Sciences Inc. - Common Stock?

The ticker symbol for Conexeu Sciences Inc. - Common Stock is CNXU on the Nasdaq Stock Market

What is the current price of Conexeu Sciences Inc. - Common Stock?

The current price of Conexeu Sciences Inc. - Common Stock is 4.520

When was Conexeu Sciences Inc. - Common Stock last traded?

The last trade of Conexeu Sciences Inc. - Common Stock was at 09/15/26 11:16 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.